JPH09315983A - Preventing and therapeutic agent for infectious disease and feed - Google Patents

Preventing and therapeutic agent for infectious disease and feed

Info

Publication number
JPH09315983A
JPH09315983A JP8156424A JP15642496A JPH09315983A JP H09315983 A JPH09315983 A JP H09315983A JP 8156424 A JP8156424 A JP 8156424A JP 15642496 A JP15642496 A JP 15642496A JP H09315983 A JPH09315983 A JP H09315983A
Authority
JP
Japan
Prior art keywords
milk whey
feed
protein concentrate
whey protein
milk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8156424A
Other languages
Japanese (ja)
Inventor
Tadakazu Tamai
忠和 玉井
Koji Oda
浩司 織田
Takeshi Okada
剛 岡田
Hiroshi Nakajima
中島  浩
Nobuyuki Sato
信行 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruha Corp
Original Assignee
Maruha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruha Corp filed Critical Maruha Corp
Priority to JP8156424A priority Critical patent/JPH09315983A/en
Publication of JPH09315983A publication Critical patent/JPH09315983A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87Re-use of by-products of food processing for fodder production

Landscapes

  • Fodder In General (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)

Abstract

PROBLEM TO BE SOLVED: To prepare a preventing and therapeutic agent for infectious diseases in fishes such as a yellowtail or a red sea-bream, crustaceans such as a prawn or a black tiger shrimp, comprising a milk whey (a hydrolyzates thereof) as an active ingredient, excellent in safety and substitutive for an antibiotic substance causing problems in development of resistant bacteria, remaining in the body, etc. SOLUTION: This preventing and therapeutic agent for infectious diseases comprises (A1 ) a milk whey or (A2 ) a hydrolyzate of the milk whey as an active ingredient. Furthermore, the agent is preferably administered in a daily dose of 1-6000mg/kg body weight, expressed in terms of the dried ingredient A1 or A2 and divided in 2 or 3 portions. The ingredient A1 is obtained by adding an acid to a milk or a skimmilk of a mammal such as a cow, a woman or a ewe and removing the produced coagulated substance. The ingredient A2 is prepared by dissolving, e.g. the ingredient A1 in water so as to provide 5-15% protein concentration, then thermally sterilizing the resultant solution, enzymically treating the sterilized solution with a proteolytic enzyme such as a pepsin, subsequently inactivating the enzyme and, as necessary, carrying out the ultrafiltering, concentrating and drying of the prepared solution.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、魚類、甲殻類の感
染症予防治療剤及び飼料に関する。
TECHNICAL FIELD The present invention relates to a preventive / therapeutic agent for fish and shellfish infections and a feed.

【0002】[0002]

【従来の技術】養魚技術は近年急速な発展を遂げ、養殖
面積(経営体数)は年々増加している。しかし、天然の
魚類、甲殻類とは違い、養殖の場合は高密度で飼育され
ているので、病気にかかるものも多い。特に病原性ウイ
ルスによる被害は甚大である。例えば、1992年の台湾で
のエビの大量へい死が、翌年、韓国、中国、及び日本に
伝播し、エビ養殖業に大きな被害をもたらした。これら
は、バキュロウイルス感染エビが、ビブリオ症に二次感
染したためと考えられている。
2. Description of the Related Art Fish farming technology has been rapidly developing in recent years, and the area of aquaculture (the number of farms) has been increasing year by year. However, unlike natural fish and crustaceans, in the case of aquaculture, they are bred at a high density, so many of them suffer from diseases. In particular, the damage caused by pathogenic viruses is enormous. For example, the mass mortality of shrimp in Taiwan in 1992 spread to South Korea, China, and Japan the following year, causing great damage to the shrimp aquaculture industry. It is believed that these are due to the secondary infection of baculovirus-infected shrimp with vibriopathies.

【0003】従来より、魚類、甲殻類の伝染性疾患に対
しては、抗生物質が使用されてきたが、耐性菌の発生
や、魚類及び甲殻類の体内での残留の問題が生じ、使用
が制限されている。これらの疾病のうち、細菌症に対し
ては抗生物質に代わるものとして、ラクトフェリン、ラ
クトフェリン分解物、及び初乳が著効を示すことが見い
出され(特開平7−48274号公報及び特開平7−1
45069号)、安全性の高い予防治療剤として研究さ
れているが、ウイルス症については、抗生物質に代わる
有効な薬剤は知られていない。また、ミルクホエー、及
びミルクホエーを酵素分解したミルクホエー分解物を魚
類、甲殻類の感染症予防治療剤又は飼料として利用する
ことに言及したものはない。
Conventionally, antibiotics have been used for infectious diseases of fish and crustaceans, but they are not used because of the occurrence of resistant bacteria and the problem of residual fish and crustaceans in the body. It is restricted. Among these diseases, lactoferrin, lactoferrin degradation products, and colostrum have been found to show remarkable effects as alternatives to antibiotics for bacteriopathies (JP-A-7-48274 and JP-A-7-274). 1
No. 45069) has been studied as a highly safe preventive / therapeutic agent, but no effective drug has been known as an alternative to antibiotics for viral diseases. Further, there is no reference to the use of milk whey and a milk whey degradation product obtained by enzymatically decomposing milk whey as a preventive / therapeutic agent for fish or crustacean infectious diseases or feed.

【0004】[0004]

【発明が解決しようとする課題】本発明の課題は、抗生
物質に代わり得る安全で優れた効果を有する魚類、甲殻
類の感染症予防治療剤及び飼料を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a preventive and therapeutic agent for fish and crustacean infectious diseases and a feed, which are safe and have excellent effects which can replace antibiotics.

【0005】[0005]

【課題を解決するための手段】本発明者等は、上記課題
を解決すべく鋭意研究を重ねた結果、ミルクホエー、又
はミルクホエー分解物が、魚類、甲殻類の感染症に有効
であることを見い出し、本発明を完成するに至った。
As a result of intensive studies to solve the above problems, the present inventors have found that milk whey or a decomposed product of milk whey is effective for infectious diseases of fish and crustaceans. The present invention has been completed.

【0006】即ち、本発明は、ミルクホエー、又はミル
クホエー分解物を有効成分とする魚類、甲殻類の感染症
予防治療剤である。本発明はまた、ミルクホエー、又は
ミルクホエー分解物を含有する魚類、甲殻類用飼料であ
る。以下、本発明を詳細に説明する。
That is, the present invention is a preventive / therapeutic agent for infectious diseases of fish and crustaceans containing milk whey or a decomposed product of milk whey as an active ingredient. The present invention is also a feed for fish and crustaceans containing milk whey or a decomposed product of milk whey. Hereinafter, the present invention will be described in detail.

【0007】[0007]

【発明の実施の形態】本発明において、予防又は治療の
対象となる魚類としては、ブリ、マダイ、クロダイ、ウ
ナギ、コイ、ニジマス、アユ、ギンザケ、シマアジ、テ
ィラピア、ヒラメ、トラフグ、フナ、グッピー、ネオン
テトラ等を挙げることができるが、これらに限定される
ものではない。また、甲殻類としては、クルマエビ、ウ
シエビ、大正エビ、ホワイトシュリンプ等が挙げられる
が、これらに限定されるものではない。
BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, fishes to be prevented or treated include yellowtail, red sea bream, black sea bream, eel, carp, rainbow trout, ayu, coho salmon, striped horse mackerel, tilapia, flounder, troughfish, crucian carp, guppy, Examples thereof include neon tetra, but are not limited thereto. Further, examples of the crustaceans include, but are not limited to, prawns, bull shrimp, Taisho shrimp, white shrimp and the like.

【0008】本発明の感染症予防治療剤の有効成分は、
ミルクホエー、又はミルクホエー分解物であり、これら
は主として牛乳から分離したものを言うが、それ以外に
もヒト、ヒツジ、ヤギ、ウマ、イヌ、ネコ等の由来のも
のも同様に有効である。これら哺乳動物の乳汁のうち、
最も普遍的な哺乳動物乳汁である牛乳を原料とすること
が入手容易性の点で適しているが、経済性の見地から牛
乳からチーズ、バター及びその他の乳成分を分離した際
に生じる副産物、乳清、あるいは脱脂乳などを原料とし
て用いてもよい。
The active ingredient of the preventive / therapeutic agent for infectious diseases of the present invention is
Milk whey or a milk whey decomposition product, which is mainly separated from milk, is not limited thereto, and those derived from humans, sheep, goats, horses, dogs, cats and the like are also effective. Of the milk of these mammals,
It is suitable from the viewpoint of availability that milk, which is the most common mammalian milk, is used as a raw material, but from the viewpoint of economy, cheese, butter and other by-products produced when separating other milk components from milk, Whey or skim milk may be used as a raw material.

【0009】ミルクホエーとは、上記哺乳動物乳汁又は
脱脂乳に酸又は凝乳酵素を加えて生じる凝固物(カー
ド)を除いた残りの水溶液をいう。また、ミルクホエー
として、市販のWPC等のミルクホエータンパク質濃縮
物あるいはWPI等のミルクホエータンパク質単離物を
用いるのが好適であるが、何ら限定されるものではな
い。
[0009] Milk whey refers to the remaining aqueous solution excluding the coagulated product (curd) produced by adding an acid or a milk-clotting enzyme to the above-mentioned mammalian milk or skim milk. As the milk whey, it is preferable to use a commercially available milk whey protein concentrate such as WPC or a milk whey protein isolate such as WPI, but the invention is not limited thereto.

【0010】また、ミルクホエー分解物とは、上記の方
法で得たミルクホエーをタンパク質分解酵素処理、ある
いは微生物による発酵、酸加水分解などを行うことによ
って得られる。例えば、タンパク質分解酵素で処理する
場合、ミルクホエー粉末、ミルクホエータンパク質濃縮
物をミルクホエー又は水を用いてタンパク質濃度5 〜15
% の範囲に溶解し、60〜130 ℃で1 秒〜30分間加熱殺菌
する。その後、必要に応じてpHを2〜10に調整した後、
酵素処理を行う。タンパク質分解酵素としては、ペプシ
ン、パンクレアチン、トリプシン、キモトリプシン、パ
パイン、プロメライン、ならびにアスペルギルス属、ス
トレプトミセス属由来のプロテアーゼ等の一種又は複数
の酵素の組み合わせが例示され、これらをミルクホエー
溶液に同時に又は分解条件に応じて分割添加し、温度範
囲を10〜70℃で3 〜24時間酵素処理し、その後、pHを5.
5 〜7.5 に調整し、80〜140 ℃で2 秒〜20分の加熱処理
によって酵素を失活させて分解液を得る。
The milk whey decomposed product is obtained by subjecting the milk whey obtained by the above method to proteolytic enzyme treatment, fermentation by microorganisms, acid hydrolysis and the like. For example, when treated with proteolytic enzymes, milk whey powder, milk whey protein concentrate is used with milk whey or water to achieve a protein concentration of 5-15.
Dissolve in the range of%, and heat sterilize at 60 to 130 ° C for 1 second to 30 minutes. Then, after adjusting the pH to 2-10 if necessary,
Enzymatic treatment is performed. Examples of the proteolytic enzyme include pepsin, pancreatin, trypsin, chymotrypsin, papain, promeline, and Aspergillus spp., And proteases derived from Streptomyces spp. Add it in portions according to the decomposition conditions, treat with an enzyme at a temperature range of 10 to 70 ° C for 3 to 24 hours, and then adjust the pH to 5.
Adjust to 5 to 7.5 and deactivate the enzyme by heat treatment at 80 to 140 ° C for 2 seconds to 20 minutes to obtain a degradation solution.

【0011】この分解液は、そのまま用いることもでき
るが、濃縮乾燥してミルクホエー分解物とし、これを用
いてもよい。あるいは分画分子量3,000 〜500,000 の限
外濾過膜で該分解液を処理し、膜を透過した分解液を濃
縮乾燥してミルクホエー分解物としたもの、又はセライ
ト濾過ないし膜細孔径0.1 〜1 μm のマイクロフィルト
レーション濾過により濾過を行って濾過液を濃縮乾燥し
てミルクホエー分解物としたものを用いてよい。
The decomposed solution may be used as it is, but may be concentrated and dried to give a milk whey decomposed product, which may be used. Alternatively, the decomposed solution was treated with an ultrafiltration membrane having a molecular weight cutoff of 3,000 to 500,000, and the decomposed solution that had permeated through the membrane was concentrated and dried to give a milk whey decomposed product, or celite filtration or a membrane pore size of 0.1 to 1 μm. A product obtained by performing filtration by microfiltration filtration and concentrating and drying the filtrate to obtain a milk whey decomposition product may be used.

【0012】本発明において用いられるミルクホエーは
分子量が 100〜800,000 、またミルクホエー分解物は分
子量が100 〜20,000のものである。
The milk whey used in the present invention has a molecular weight of 100 to 800,000, and the decomposed product of milk whey has a molecular weight of 100 to 20,000.

【0013】上記のミルクホエー、又はミルクホエー分
解物を濃縮乾燥し、粉砕した後に適量のトウモロコシデ
ンプン、タルク、ステアリン酸マグネシウム等とともに
充分混和し、常法により粒度を調整することにより製剤
化する。製剤中のミルクホエー、又はミルクホエー分解
物含有量は、特に限定はされないが、散剤から造粒する
時は、魚類や甲殻類の種類により、又はその成長段階に
合わせて適宜調整すればよい。
The above milk whey or a decomposed product of milk whey is concentrated and dried, pulverized, and then thoroughly mixed with an appropriate amount of corn starch, talc, magnesium stearate, etc., and the particle size is adjusted by a conventional method to prepare a formulation. The content of milk whey or a decomposed product of milk whey in the preparation is not particularly limited, but when granulating from a powder, it may be appropriately adjusted depending on the type of fish or crustacean or according to its growth stage.

【0014】一方、飼料を調製するには、通常養殖に用
いられる飼料原料を、対象とする水産動物に応じて適宜
選択、配合し、これに上記のミルクホエー又はミルクホ
エー分解物を添加、配合、湿潤すればよい。飼料原料と
しては、一般的には魚粉、エビミール、イカミール、小
麦粉、コーングルテン、ビール酵母、コレステロール、
ビタミン、ミネラルが用いられる。飼料に上記ミルクホ
エー、又はミルクホエー分解物を添加、配合、湿潤する
際には、全飼料中0.01〜5 重量%となるようにすればよ
い。
On the other hand, in order to prepare a feed, the feed raw material usually used in aquaculture is appropriately selected and blended according to the target aquatic animal, and the above milk whey or a decomposed product of milk whey is added thereto, blended and moistened. do it. As feed ingredients, generally, fish meal, shrimp meal, squid meal, wheat flour, corn gluten, brewer's yeast, cholesterol,
Vitamins and minerals are used. When the above milk whey or the decomposed product of milk whey is added to, mixed with and moistened with the feed, the content may be 0.01 to 5% by weight in the total feed.

【0015】本発明の感染症予防治療剤ならびに飼料に
よって、治療又は予防されうる感染症としては、魚類、
甲殻類のウイルス感染症、細菌感染症である。ウイルス
感染症としては、具体的には、ヒラメのヒラメラブドウ
イルス感染症、トラフグの口白症ウイルス、ニジマスの
伝染性膵臓壊死症, ウイルス性出血性敗血症,伝染性造
血器壊死症、コイの春ウイルス病, 鰾炎症、ナマズのウ
イルス病、サケのヘルペスウイルス病、Pike(カワカマ
ス)稚魚のウイルス病、シマアジのイリドウイルス感染
症、マダイのイリドウイルス感染症、ウナギのウイルス
性鰓病、ギンザケの伝染性膵臓壊死症, 伝染性造血器壊
死症, ヘルペスウイルス感染症, Erythrocytic Inclus
ion Body Syndrome ウイルス感染症、クルマエビのRod
shapaedvirus-Penaeus japonicus 感染症、ウシエビの
黄頭症、多くの海水及び淡水魚に感染するリンホシスチ
ス病等が挙げられるが、これらに限定されない。
Infectious diseases which can be treated or prevented by the preventive / therapeutic agent for infectious diseases and the feed of the present invention include fish,
It is a viral or bacterial infection of crustaceans. Specific examples of viral infections include Japanese flounder flounder melabud virus infection, trough puffer disease virus, rainbow trout infectious pancreatic necrosis, viral hemorrhagic sepsis, infectious hematopoietic necrosis, and carp spring. Viral disease, fin inflammation, catfish viral disease, salmon herpesvirus disease, Pike fry viral disease, striped horse mackerel iridovirus infection, red sea bream iridovirus infection, eel viral gills disease, coho salmon transmission Pancreatic necrosis, infectious hematopoietic necrosis, herpesvirus infection, Erythrocytic Inclus
ion Body Syndrome Virus infection, Rod of prawns
Examples include, but are not limited to, shapaedvirus-Penaeus japonicus infectious disease, bald shrimp's jaundice, lymphocystis disease that infects many seawater and freshwater fish, and the like.

【0016】また、細菌感染症としては、具体的には、
トラフグ、ニジマスのVibrio anguillarum感染症、ブリ
のPseudotuberculosis感染症, 類結症, 連鎖球菌感染
症、クロダイのFlexibacter maritimus 感染症、ウシエ
ビのビブリオ(Vibrio vulnificus) 感染症、クルマエビ
のビブリオ感染症、タイのビブリオ感染症, Edwardsiel
la tardaa 感染症、ウナギのパラコロ病等が挙げられる
が、これらに限定されない。
Further, as the bacterial infection, specifically,
Vibrio anguillarum infection of trout, rainbow trout, Pseudotuberculosis infection of yellowtail, congenital disease, streptococcal infection, Flexibacter maritimus infection of black sea bream, Vibrio vulnificus infection of prawns, vibrio infection of prawns, vibrio infection of Thailand Infectious disease, Edwardsiel
Examples include, but are not limited to, la tardaa infection, eel paracolo disease, and the like.

【0017】本発明にいう感染症予防治療剤とは、上記
の感染症の感染及び発病の予防、あるいは発病したもの
を治療するものをいう。
The prophylactic / therapeutic agent for infectious disease as used in the present invention refers to an agent for preventing infection and onset of the above-mentioned infectious diseases, or for treating the infected one.

【0018】本発明の感染症予防治療剤又は飼料の投与
量、投与時期は適用する魚類、甲殻類の種類、感染症の
種類等により適宜変更しうるが、例えば乾燥したミルク
ホエー、又はミルクホエー分解物として1 〜6,000mg/kg
体重を1日に2〜3回に分けて与えればよい。また、本
発明の魚類及び甲殻類の感染症予防治療剤又は飼料を稚
魚期に与えておけば予防的効果が得られる。
The dose and timing of administration of the preventive / therapeutic agent for infectious disease or feed of the present invention may be appropriately changed depending on the type of fish, crustacea, type of infectious disease, etc. to be applied. As 1 to 6,000 mg / kg
The weight may be given in two to three times a day. In addition, a preventive effect can be obtained by giving the fish or crustacean infectious disease preventive / therapeutic agent or feed of the present invention during the juvenile stage.

【0019】[0019]

【実施例】以下、参考例、実施例、試験例を挙げて本発
明を更に詳細に説明するが、これらは本発明の範囲を何
等限定するものではない。
EXAMPLES The present invention will be described in more detail below with reference to Reference Examples, Examples and Test Examples, but these do not limit the scope of the present invention in any way.

【0020】〔参考例1〕 ミルクホエータンパク質濃
縮物の調製 脱脂粉乳に硫酸を加え、カゼインを等電点沈殿させた
後、これを取り除き、更に残った硫酸ホエー中の不溶物
や雑菌をクラリファイヤーで除いた。その後、限外濾過
モジュールにて固形含量が15% 以上になるまで濃縮し、
更にpHを中和後、エバポレーターで固形含量が25% 以上
になるまで濃縮した。この濃縮液を常法によってスプレ
ードライヤーで乾燥し、ミルクホエータンパク質濃縮物
を得た。
[Reference Example 1] Preparation of Milk Whey Protein Concentrate Sulfuric acid was added to skim milk to precipitate casein at an isoelectric point, which was then removed, and the remaining insoluble matter and various bacteria in the sulfuric acid whey were clarified. I excluded it. After that, concentrate with an ultrafiltration module until the solid content is 15% or more,
After further neutralizing the pH, the mixture was concentrated with an evaporator until the solid content became 25% or more. This concentrate was dried by a spray dryer by a conventional method to obtain a milk whey protein concentrate.

【0021】〔参考例2〕 ミルクホエータンパク質濃
縮物分解物の調製 (その1)市販のミルクホエータンパク質濃縮物(WP
C:タンパク質含量80% )1kgを9kg の精製水に溶解
し、プレート型殺菌装置で75℃15秒間殺菌し、のち水酸
化ナトリウムを添加して溶液のpHを9.0 に調整し、バチ
ルス・ズブチルス菌由来のプロテアーゼ製剤10g、トリ
プシン4g、及びパパイン4gを添加し、55℃で5時間
分解した後、90℃で20分間加熱して酵素を失活させた。
次いで、常法により濃縮し、乾燥し、粉末状のミルクホ
エータンパク質濃縮物分解物950gを得た。
Reference Example 2 Preparation of Decomposed Product of Milk Whey Protein Concentrate (1) Commercially Available Milk Whey Protein Concentrate (WP
C: Protein content 80%) 1 kg was dissolved in 9 kg of purified water, sterilized by a plate type sterilizer at 75 ° C. for 15 seconds, and then sodium hydroxide was added to adjust the pH of the solution to 9.0. Bacillus subtilis 10 g of the protease preparation derived from the above, 4 g of trypsin, and 4 g of papain were added, and after decomposing at 55 ° C. for 5 hours, the enzyme was inactivated by heating at 90 ° C. for 20 minutes.
Then, it was concentrated by a conventional method and dried to obtain 950 g of a powdery milk whey protein concentrate hydrolyzate.

【0022】(その2)市販のミルクホエータンパク質
濃縮物(WPC:タンパク質含量80% )1kgを9kgの精
製水に溶解し、プレート型殺菌装置で75℃15秒間殺菌
し、のち水酸化ナトリウムを添加して溶液をpH8.5 に調
整し、バチルス・ズブチルス菌由来のプロテアーゼ製剤
8gを添加した後、pHを8.0 に保ったまま30分経過後、
トリプシン4gを添加し、50℃で6 時間分解した。その
後、85℃で15分間加熱して酵素を失活させた。ついで、
常法により濃縮し、乾燥し、粉末状のミルクホエータン
パク質濃縮物分解物940gを得た。
(Part 2) 1 kg of commercially available milk whey protein concentrate (WPC: protein content 80%) was dissolved in 9 kg of purified water, sterilized with a plate type sterilizer at 75 ° C. for 15 seconds, and sodium hydroxide was added thereafter. Then, the solution was adjusted to pH 8.5, and 8 g of the Bacillus subtilis-derived protease preparation was added. After 30 minutes while keeping the pH at 8.0,
4 g of trypsin was added, and the mixture was decomposed at 50 ° C. for 6 hours. Then, the enzyme was inactivated by heating at 85 ° C for 15 minutes. Then
It was concentrated by a conventional method and dried to obtain 940 g of a powdery milk whey protein concentrate decomposition product.

【0023】(その3)市販のミルクホエータンパク質
濃縮物(WPC:タンパク質含量80%)100kg を900kg の
精製水に溶解し、プレート型殺菌装置で75℃15秒間殺菌
し、のち水酸化ナトリウムを添加して溶液のpHを9.0 に
調整し、バチルス・ズブチルス菌由来のプロテアーゼ製
剤1kgを添加し、50℃に保持して加水分解し、8時間
後に120℃で2秒間の加熱処理によって酵素を失活さ
せ、冷却し、のち塩酸によってpHを6.0 に調整し、分画
分子量10,000の限外濾過膜で限外濾過し、のち常法によ
り濃縮し、乾燥し、粉末状のミルクホエータンパク質濃
縮物分解物85kgを得た。
(Part 3) 100 kg of commercially available milk whey protein concentrate (WPC: protein content 80%) was dissolved in 900 kg of purified water, sterilized by a plate type sterilizer at 75 ° C. for 15 seconds, and then sodium hydroxide was added. Then, the pH of the solution is adjusted to 9.0, 1 kg of a Bacillus subtilis-derived protease preparation is added, and the mixture is kept at 50 ° C for hydrolysis, and after 8 hours, the enzyme is inactivated by heat treatment at 120 ° C for 2 seconds. After cooling, cooling, adjusting the pH to 6.0 with hydrochloric acid, ultrafiltration with an ultrafiltration membrane with a cut-off molecular weight of 10,000, then concentrating by the usual method, drying, and decomposing powdery milk whey protein concentrate. Got 85 kg.

【0024】〔参考例3〕 ラクトフェリンの調製 牛ラクトフェリンは、牛生乳からロウとライターの方法
[B.A.LAW & B. Reiter 、ジャーナル・オブ・デイリー
・リサーチ(Journal of Dairy Research) 、第44巻、第
595 〜599 頁、1977年] により調製した。牛生乳(450L)
に1モル塩酸を添加し、pHを6.3 に調整し、100gのレン
ネット(ハンセル社製) を32℃の温度で添加した。30分
後、析出したカードを除去し、ミルクホエーを得た。ミ
ルクホエーを限外濾過法により約20倍に濃縮し、濃縮ミ
ルクホエー(10L) に、予め0.05M トリス塩酸緩衝液(pH
8.0) で平衡化したCM・Sephadex C-50 樹脂(ファルマ
シア社製)4 L を添加し、4 ℃で1 時間攪拌し、のち放
置し、上清を除去した。樹脂をカラム(90 ×9cm)に充填
し、0.05M トリス塩酸緩衝液(pH8.0) 約3Lを通液して樹
脂を洗浄し、次いで、0.2M食塩を含む0.05M トリス塩酸
緩衝液(pH8.0) 約5Lを通液し、最後に0.05M 食塩を含む
0.05M トリス塩酸緩衝液(pH8.0) 約2Lを通液し、ラクト
フェリンを溶出させた。この溶出液を限外濾過装置でダ
イヤフィルトレーションし、脱塩し、凍結乾燥し、粉末
状のラクトフェリン約8gを得た。
[Reference Example 3] Preparation of lactoferrin Bovine lactoferrin was prepared from raw milk by the method of wax and lighter.
[BALAW & B. Reiter, Journal of Dairy Research, Vol. 44, Vol.
595-599, 1977]. Raw milk (450L)
1 mol hydrochloric acid was added thereto to adjust the pH to 6.3, and 100 g of Rennet (manufactured by Hansel) was added at a temperature of 32 ° C. After 30 minutes, the precipitated curd was removed to obtain milk whey. Concentrate milk whey approximately 20 times by ultrafiltration and concentrate it in concentrated milk whey (10 L) in advance with 0.05 M Tris-HCl buffer (pH
4 L of CM Sephadex C-50 resin (Pharmacia) equilibrated with 8.0) was added, and the mixture was stirred at 4 ° C for 1 hour, then left to stand and the supernatant was removed. The resin was packed in a column (90 × 9 cm), 0.05 M Tris-HCl buffer (pH 8.0) was passed through about 3 L to wash the resin, and then 0.05 M Tris-HCl buffer (pH 8) containing 0.2 M sodium chloride was added. .0) Approximately 5 L is passed through and finally contains 0.05M sodium chloride.
About 2 L of 0.05 M Tris-HCl buffer (pH 8.0) was passed through to elute lactoferrin. This eluate was diafiltered with an ultrafiltration device, desalted and freeze-dried to obtain about 8 g of powdered lactoferrin.

【0025】〔参考例4〕 ラクトフェリン分解物の調
製 参考例3と同一の方法により調製した牛ラクトフェリン
を、精製水に50g/950ml の割合で溶解し、得られた溶液
に塩酸を添加してpHを3.0 に調整し、のち市販の豚ペプ
シン(和光純薬社製)をラクトフェリン50gに対して1
gの割合で添加し、37℃で6時間加水分解した。次い
で、6M水酸化ナトリウムでpHを7.00に調整し、80℃で
10分間加熱して酵素を失活させ、室温に冷却し、不溶物
を濾去し、濾液を凍結乾燥して粉末状のラクトフェリン
分解物約45g を得た。
[Reference Example 4] Preparation of lactoferrin degradation product Bovine lactoferrin prepared by the same method as in Reference Example 3 was dissolved in purified water at a rate of 50 g / 950 ml, and hydrochloric acid was added to the resulting solution to adjust pH. Was adjusted to 3.0, and then commercially available pork pepsin (manufactured by Wako Pure Chemical Industries, Ltd.) was added to 1 per 50 g of lactoferrin.
It was added at a rate of g and hydrolyzed at 37 ° C. for 6 hours. Then, adjust the pH to 7.00 with 6M sodium hydroxide, and at 80 ℃
The enzyme was inactivated by heating for 10 minutes, cooled to room temperature, the insoluble matter was filtered off, and the filtrate was freeze-dried to obtain about 45 g of powdery lactoferrin degradation product.

【0026】〔参考例5〕 牛初乳粉末の調製 分娩後3日以内の牛初乳3kgを濾過布で濾別し、水酸化
ナトリウムを添加して初乳の滴定乳酸度を0.30% に調整
し、次いで攪拌しながら63℃、30分間の保持殺菌を行
い、スプレードライヤーを用いて噴霧乾燥し、初乳粉末
約 395gを得た。 〔実施例1〕 感染症予防治療剤の調製 参考例2(その1)と同様のミルクホエータンパク質濃
縮物分解物200kg 、トウモロコシデンプン150kg 、タル
ク80kg及びステアリン酸マグネシウム30kgを十分混和
し、60メッシュの金網を通過させて粒度を調整し、本発
明の感染症予防治療剤を得た。
Reference Example 5 Preparation of Cow Colostrum Powder 3 kg of bovine colostrum within 3 days after calving are filtered off with a filter cloth, and sodium hydroxide is added to adjust the titrated lactic acid content of colostrum to 0.30%. Then, the mixture was held and sterilized at 63 ° C. for 30 minutes while stirring, and spray-dried using a spray dryer to obtain about 395 g of colostrum powder. [Example 1] Preparation of prophylactic / therapeutic agent for infectious diseases 200 kg of milk whey protein concentrate hydrolyzate, 150 kg of corn starch, 80 kg of talc and 30 kg of magnesium stearate similar to those in Reference Example 2 (No. 1) were thoroughly mixed to prepare a 60 mesh powder. The particle size was adjusted by passing through a wire net to obtain the infectious disease preventive and therapeutic agent of the present invention.

【0027】〔実施例2〕 養殖エビ用飼料の調製 クルマエビ用基礎飼料〔林兼産業(株)社製〕にミルク
ホエータンパク質濃縮物(WPC 、タンパク質含量80%)、
又は参考例2(その2)と同様にして作製したミルクホ
エータンパク質濃縮物分解物を3重量%添加した。得ら
れた配合物を90℃以上で5 分間蒸すことでグルテンを変
性させて要求される保型性を付与し、その後、80℃で数
時間熱風乾燥し、ペレットマシーンを用いてペレット状
(2mm φ×5mm)に成形し、ミルクホエータンパク質濃縮
物、又はミルクホエータンパク質濃縮物分解物を含む、
それぞれ2種のクルマエビ用飼料を得た。
Example 2 Preparation of Feed for Cultured Shrimp A basic feed for prawns [made by Hayashikane Sangyo Co., Ltd.] and milk whey protein concentrate (WPC, protein content 80%),
Alternatively, 3% by weight of the decomposed product of milk whey protein concentrate prepared in the same manner as in Reference Example 2 (No. 2) was added. The resulting formulation is steamed at 90 ° C or above for 5 minutes to modify the gluten and impart the required shape retention property, then dried with hot air at 80 ° C for several hours and pelletized (2 mm (φ × 5 mm) and contains milk whey protein concentrate or milk whey protein concentrate degradation product,
Two kinds of prawn feed were obtained for each.

【0028】〔実施例3〕 養殖トラフグ用飼料の調製 市販のトラフグ用飼料基礎粉末〔大洋飼料(株)社製〕
に、ミルクホエータンパク質濃縮物(WPC 、タンパク質
含量80%)、又は参考例2(その3)と同様にして作製し
たミルクホエータンパク質濃縮物分解物を3重量%添加
した。得られた配合物をペレットマシーンを用いて成形
(5mmφ×10mm) して、40℃にて5 時間乾燥してミルクホ
エータンパク質濃縮物、又はミルクホエータンパク質濃
縮物分解物を含む、それぞれ2種のトラフグ用ドライペ
レットを得た。
[Example 3] Preparation of feed for cultured troughs [0028] Commercial feed basic powder for troughs [manufactured by Taiyo Feed Co., Ltd.]
To this, 3% by weight of milk whey protein concentrate (WPC, protein content 80%) or a decomposed product of milk whey protein concentrate prepared in the same manner as in Reference Example 2 (Part 3) was added. Mold the resulting blend using a pellet machine
(5 mmφ × 10 mm) and dried at 40 ° C. for 5 hours to obtain two types of dry pellets for troughs containing milk whey protein concentrate or milk whey protein concentrate degradation product.

【0029】〔実施例4〕 養殖マス用飼料の調製 市販のマス稚魚用飼料基礎粉末〔大洋飼料(株)社製〕
に、参考例1のミルクホエータンパク質濃縮物、又は参
考例2(その2)と同様にして作製したミルクホエータ
ンパク質濃縮物分解物を3重量%添加した。得られた配
合物をペレットマシーンを用いて成形(2mmφ×3 mm) し
て、40℃にて5 時間乾燥してミルクホエータンパク質濃
縮物、又はミルクホエータンパク質濃縮物分解物を含
む、それぞれ2種のマス稚魚用ドライペレットを得た。
[Example 4] Preparation of feed for cultured trout Commercially available feed powder for trout fry [manufactured by Taiyo Feed Co., Ltd.]
3% by weight of the milk whey protein concentrate of Reference Example 1 or the decomposed product of milk whey protein concentrate prepared in the same manner as in Reference Example 2 (Part 2) was added. The resulting blend was molded using a pellet machine (2 mmφ × 3 mm) and dried at 40 ° C for 5 hours to contain milk whey protein concentrate or milk whey protein concentrate decomposed product, 2 types each To obtain dry pellets for trout fry.

【0030】〔実施例5〕 養殖ヒラメ用飼料の調製 市販のヒラメ用ドライペレット飼料〔大洋飼料(株)社
製、5mm φ×5mm 〕100gに、ミルクホエータンパク質濃
縮物(WPC 、タンパク質含量75%)、又は参考例2(その
1)と同様にして作製したミルクホエータンパク質濃縮
物分解物の懸濁液(3g/ml)100mlを噴霧した後、30℃にて
3 時間乾燥することで、ミルクホエータンパク質濃縮
物、又はミルクホエータンパク質濃縮物分解物を含む、
それぞれ2種のヒラメ用飼料を得た。
Example 5 Preparation of Cultured Flounder Feed for Commercial Flounder Dry Pellet Feed for Flounder (Taiyo Feed Co., Ltd., 5 mm φ × 5 mm) 100 g, milk whey protein concentrate (WPC, protein content 75%) ), Or 100 ml of a suspension (3 g / ml) of a decomposed product of milk whey protein concentrate prepared in the same manner as in Reference Example 2 (Part 1), and then at 30 ° C.
By drying for 3 hours, it contains milk whey protein concentrate or milk whey protein concentrate degradation product,
Two kinds of flounder feeds were obtained respectively.

【0031】〔実施例6〕 養殖ギンザケ用飼料の調製 市販のギンザケ用飼料基礎粉末〔大洋飼料(株)社製〕
に、参考例1のミルクホエータンパク質濃縮物、又は参
考例2(その2)と同様にして作製したミルクホエータ
ンパク質濃縮物分解物を3重量%添加した。得られた配
合物をペレットマシーンを用いて成形(2mmφ×3 mm) し
て、40℃にて5 時間乾燥してミルクホエータンパク質濃
縮物、又はミルクホエータンパク質濃縮物分解物を含
む、それぞれ2種のギンザケ用飼料を得た。
[Example 6] Preparation of feed for cultured coho salmon Commercially available feed powder for coho salmon [manufactured by Taiyo Feed Co., Ltd.]
3% by weight of the milk whey protein concentrate of Reference Example 1 or the decomposed product of milk whey protein concentrate prepared in the same manner as in Reference Example 2 (Part 2) was added. The resulting blend was molded using a pellet machine (2 mmφ × 3 mm) and dried at 40 ° C for 5 hours to contain milk whey protein concentrate or milk whey protein concentrate decomposed product, 2 types each A coho salmon feed was obtained.

【0032】〔実施例7〕 養殖シマアジ用飼料の調製 市販のシマアジ用飼料基礎粉末〔大洋飼料(株)社製〕
に、ミルクホエータンパク質濃縮物、又は参考例2(そ
の3)と同様にして作製したミルクホエータンパク質濃
縮物分解物を3重量%添加した。得られた配合物をペレ
ットマシーンを用いて成形(8mmφ×10mm) して、40℃に
て5 時間乾燥してミルクホエータンパク質濃縮物、又は
ミルクホエータンパク質濃縮物分解物を含む、それぞれ
2種のシマアジ用飼料を得た。
[Example 7] Preparation of feed for cultured striped horse mackerel Commercially available feed powder for striped horse mackerel [manufactured by Taiyo Feed Co., Ltd.]
3% by weight of milk whey protein concentrate or a decomposed product of milk whey protein concentrate prepared in the same manner as in Reference Example 2 (Part 3) was added. The obtained compound was molded using a pellet machine (8 mmφ × 10 mm) and dried at 40 ° C. for 5 hours to contain milk whey protein concentrate or milk whey protein concentrate decomposed product, each of two types. A feed for striped horse mackerel was obtained.

【0033】〔実施例8〕 養殖マダイ用飼料の調製 市販のマダイ用飼料基礎粉末〔大洋飼料(株)社製〕
に、参考例1と同様にして作製したミルクホエータンパ
ク質濃縮物、又は参考例2(その3)と同様にして作製
したミルクホエータンパク質濃縮物分解物を3重量%添
加した。得られた配合物をペレットマシーンを用いて成
形(2mmφ×3mm)して、40℃にて5 時間乾燥してミルクホ
エータンパク質濃縮物、又はミルクホエータンパク質濃
縮物分解物を含む、それぞれ2種のマダイ用飼料を得
た。
[Example 8] Preparation of feed for cultured red sea bream Commercially available feed basic powder for red sea bream [manufactured by Taiyo Feed Co., Ltd.]
3% by weight of the milk whey protein concentrate prepared in the same manner as Reference Example 1 or the decomposed product of milk whey protein concentrate prepared in the same manner as Reference Example 2 (Part 3) was added. The obtained mixture was molded (2 mmφ × 3 mm) using a pellet machine, dried at 40 ° C. for 5 hours, and contained milk whey protein concentrate or milk whey protein concentrate decomposed product. We obtained red sea bream feed.

【0034】〔試験例1〕 エビRod shaped virus-Pen
aeus japonicus (RV-PJ)ウイルスに対する感染予防効果 RV-PJに感染してへい死したクルマエビの中腸腺周辺を
摘出し、10倍量の緩衝液を加えてホモジナイズした抽出
液をポアサイズ0.2 μmのフィルターでろ過したものを
健常なエビの腹部筋中に注入すると、甲皮の白斑等の本
感染症特有の症状を伴ってへい死した。さらに、電子顕
微鏡観察によって、本感染症はバキュロウイルスに属す
ると思われるウイルスによって引き起こされることがわ
かった。そこで、ミルクホエータンパク質濃縮物、又は
ミルクホエータンパク質濃縮物分解物を含む2種のクル
マエビ用飼料、及び感染症予防治療剤をクルマエビに与
え、 RV-PJ感染症に対する予防効果を調べた。
[Test Example 1] Shrimp Rod shaped virus-Pen
Preventive effect against infection with aeus japonicus (RV-PJ) virus The midgut gland around the gut of prawns infected with RV-PJ was excised, and a homogenized extract containing 10 volumes of buffer was added to a 0.2 μm pore size filter. When it was injected into the abdominal muscle of healthy shrimp, it died with the symptoms peculiar to this infection such as vitiligo on the instep. Furthermore, electron microscopic observation revealed that this infection was caused by a virus that seems to belong to the baculovirus. Therefore, two kinds of prawn feed containing milk whey protein concentrate or milk whey protein concentrate degradation product and a preventive and therapeutic agent for infectious diseases were given to prawns, and the preventive effect against RV-PJ infection was examined.

【0035】健常なクルマエビ(平均体重22g)に、1日
2回上記実施例1で得られた感染症治療剤を6重量%と
なるようイガイミンチ肉に十分混和させたもの、上記実
施例2で得られたミルクホエータンパク質濃縮物、又は
ミルクホエータンパク質濃縮物分解物を含む2種の養殖
エビ用試料、比較としてラクトフェリン、ラクトフェリ
ン分解物、初乳粉末3%添加飼料を、1 日当たり体重の
1%量与えた。各投与群は、一群あたり10尾とした。ま
た、添加物を添加しない飼料を与える群をコントロール
とした。飼料投与を初めてから14日目に一群当たり10尾
のクルマエビに、上記と同様にして得られたウイルス液
を80倍希釈したものを100μl ずつ、又はブランクとし
て緩衝液を注入し、その後のへい死率を調べた。結果を
表1に示す。
Healthy prawns (average body weight: 22 g) were thoroughly mixed twice a day with the therapeutic agent for infectious disease obtained in the above Example 1 to 6% by weight of mussel minced meat, in the above Example 2. The obtained milk whey protein concentrate or two kinds of shrimp samples containing milk whey protein concentrate degradation product, for comparison, lactoferrin, lactoferrin degradation product, colostrum powder 3% feed, 1% of body weight per day Given the amount. Each administration group had 10 fish per group. In addition, a group fed a feed to which no additive was added was used as a control. On the 14th day after the first administration of the feed, 100 μl of the virus solution obtained in the same manner as above was diluted 80-fold to 100 prawns per group, or a buffer solution was injected as a blank, and the mortality rate after that I checked. The results are shown in Table 1.

【0036】[0036]

【表1】 [Table 1]

【0037】健常なエビにRV-PJ ウイルスを感染させる
と、7 日後にはへい死率が6割となるが、本発明の感染
症予防治療剤、ミルクホエータンパク質濃縮物、ミルク
ホエータンパク質濃縮物分解物添加飼料を与えていたも
のは、へい死率の低下が認められた。特に感染症予防治
療剤及びミルクホエータンパク質濃縮物分解物添加飼料
の投与で、へい死率をそれぞれ3割、及び2割までくい
止めることができ、その効果は顕著であった。一方、ラ
クトフェリン、ラクトフェリン分解物、初乳粉末添加飼
料ではへい死率がコントロールと同様の6割であり、効
果は認められなかった。尚、ウイルスを感染させないエ
ビ(ブランク)は試験期間中全くへい死しなかった。
When healthy shrimp were infected with the RV-PJ virus, the mortality rate after death was 60% after 7 days, but the preventive and therapeutic agent for infectious diseases of the present invention, milk whey protein concentrate, milk whey protein concentrate degradation A reduction in the mortality rate was observed in those fed the supplemented diet. In particular, administration of a prophylactic / therapeutic agent for infectious disease and a feed containing a decomposed product of a milk whey protein concentrate could suppress the mortality to 30% and 20%, respectively, and the effect was remarkable. On the other hand, in the lactoferrin, the lactoferrin degradation product, and the colostrum powder-added feed, the mortality rate was 60%, which was the same as the control, and no effect was observed. The shrimp (blank) not infected with the virus did not die at all during the test.

【0038】〔試験例2〕 トラフグ(Takifugu rubrip
es) を用いた口白症ウイルスに対する感染予防効果 健常なトラフグ(平均体重50g)に上記実施例3で得られ
た、ミルクホエータンパク質濃縮物、又はミルクホエー
タンパク質濃縮物分解物を含む2種のトラフグ用飼料、
比較としてラクトフェリン、ラクトフェリン分解物、初
乳粉末3%添加飼料を1 日当たり体重の5%量与えた。
各飼料投与群は、一群あたり10尾とした。また、添加物
を添加しない飼料を与える群をコントロールとした。飼
料投与を初めてから14日目に一群あたり10尾のトラフグ
に1 ×103.7TCID50/mlの力価の口白症ウイルス液を0.1m
l ずつ背部の皮下に接種し、その後のへい死率を調べ
た。結果を表2に示す。
Test Example 2 Takifugu rubrip
es) to prevent infection of the disease of white-spots virus using healthy troughfish (average weight of 50 g) containing two types of milk whey protein concentrate or a milk whey protein concentrate degradation product obtained in Example 3 above. Feed for troughs,
For comparison, lactoferrin, a lactoferrin degradation product, and a diet containing 3% colostrum powder were given in an amount of 5% of the body weight per day.
Each feed-administered group had 10 fish per group. In addition, a group fed a feed to which no additive was added was used as a control. On the 14th day after the first administration of the feed, 0.1m of the oral virus of the leukoporosis having a titer of 1 × 10 3.7 TCID 50 / ml was applied to 10 troughs per group.
l of each was subcutaneously inoculated on the back, and the mortality rate after that was examined. Table 2 shows the results.

【0039】[0039]

【表2】 [Table 2]

【0040】健常なトラフグに口白症ウイルスを感染さ
せると、7 日後にはへい死率が8割となるが、本発明の
ミルクホエータンパク質濃縮物、ミルクホエータンパク
質濃縮物分解物添加飼料を与えていたものはへい死率の
低下が認められ、特にミルクホエータンパク質濃縮物分
解物添加飼料ではへい死率を1割にくい止めることがで
き、その効果が顕著であった。また、ミルクホエータン
パク質濃縮物添加飼料投与群でのへい死率は5割であっ
た。一方、ラクトフェリン、ラクトフェリン分解物、初
乳粉末添加飼料ではへい死率がコントロールと同様の8
割であり、効果は認められなかった。尚、ウイルスを感
染させないトラフグ(ブランク)のへい死率は1割であ
った。
Infection of a healthy troughfish with the oral disease virus results in 80% mortality after 7 days. However, the milk whey protein concentrate and the milk whey protein concentrate degradation product-added feed of the present invention were fed. A decrease in the mortality rate was observed, and particularly in the milk whey protein concentrate hydrolyzate-added feed, the mortality rate could be suppressed to less than 10%, and the effect was remarkable. Further, the mortality rate in the group administered with the milk whey protein concentrate-added feed was 50%. On the other hand, in the lactoferrin, lactoferrin degradation product, and colostrum powder-added feed, the mortality rate was 8
However, no effect was observed. The mortality rate of the tiger pufferfish (blank) that was not infected with the virus was 10%.

【0041】〔試験例3〕 ニジマス(Oncorhynchus my
kiss) を用いた伝染性膵臓壊死症ウイルス(IPNV)に対す
る感染予防効果 健常なニジマス(平均体重4g) に上記の実施例4で得ら
れたミルクホエータンパク質濃縮物、又はミルクホエー
タンパク質濃縮物分解物を含む2種のニジマス用飼料、
比較としてラクトフェリン、ラクトフェリン分解物、初
乳粉末3%添加飼料を1 日当たり体重の20% 量与えた。
各飼料投与群は、一群あたり10尾とした。また、添加物
を添加しない飼料を与える群をコントロールとした。飼
料投与を初めてから14日目に一群あたり10尾のニジマス
に5 ×104.8TCID50/mlの力価のIPNV液を50μl ずつ静脈
投与した。結果を表3に示す。
Test Example 3 Rainbow trout (Oncorhynchus my
Infection prevention effect against infectious pancreatic necrosis virus (IPNV) using kiss) Healthy rainbow trout (average body weight: 4 g) was added to the milk whey protein concentrate or the milk whey protein concentrate degradation product obtained in Example 4 above. Two species of rainbow trout feed containing
For comparison, lactoferrin, a lactoferrin degradation product, and a diet containing 3% colostrum powder were given in an amount of 20% of the body weight per day.
Each feed-administered group had 10 fish per group. In addition, a group fed a feed to which no additive was added was used as a control. On the 14th day after the first administration of the feed, 50 μl of IPNV solution having a titer of 5 × 10 4.8 TCID 50 / ml was intravenously administered to 10 rainbow trouts per group. The results are shown in Table 3.

【0042】[0042]

【表3】 [Table 3]

【0043】健常なニジマスにIPNVを感染させると、10
日後にはへい死率が8割となるが、本発明のミルクホエ
ータンパク質濃縮物、ミルクホエータンパク質濃縮物分
解物添加飼料を与えていたものは、へい死率の低下が認
められ、特にミルクホエータンパク質濃縮物分解物添加
飼料ではへい死率を1割にくい止めることができ、その
効果が顕著であった。一方、ラクトフェリン、ラクトフ
ェリン分解物、初乳粉末添加飼料ではへい死率がコント
ロールと同様の8割であり、効果は認められなかった。
尚、ウイルスを感染させないニジマス(ブランク)は試
験期間中全くへい死しなかった。
When a healthy rainbow trout was infected with IPNV, 10
After a day, the mortality rate is 80%, but the milk whey protein concentrate of the present invention and the feed containing the decomposed product of the milk whey protein concentrate show a decrease in the mortality rate, especially the milk whey protein concentration. It was possible to reduce the mortality rate to 10% or less with the feed containing the decomposed product, and the effect was remarkable. On the other hand, in the lactoferrin, the lactoferrin degradation product, and the colostrum powder-added feed, the mortality rate was 80% as in the control, and no effect was observed.
Rainbow trout (blank) not infected with the virus did not die at all during the test period.

【0044】〔試験例4〕 ヒラメ(Paralichthys oliv
aceus)を用いたラブドウイルス(HRV)に対する感染予防
効果 実施例5で得られたミルクホエータンパク質濃縮物、又
はミルクホエータンパク質濃縮物分解物を含むヒラメ用
飼料をヒラメに与え、HRV に対する感染予防効果を調べ
た。健常なヒラメ(平均体重80g)に上記の実施例5で得
られたミルクホエータンパク質濃縮物、又はミルクホエ
ータンパク質濃縮物分解物を含む2種のヒラメ用飼料、
比較としてラクトフェリン、ラクトフェリン分解物、初
乳粉末3%添加飼料を1 日当たり体重の5%量を2回に
分けて与えた。各飼料投与群は、一群あたり10尾とし
た。また、添加物を添加しない飼料を与える群をコント
ロールとした。飼料投与を初めてから14日目に一群あた
り10尾のヒラメに5 ×106.8TCID50/mlの力価のHRV 液を
0.1ml ずつ静脈投与した。結果を表4に示す。
Test Example 4 Flounder (Paralichthys oliv)
(Aceus) against rhabdovirus (HRV) infection prevention effect The flounder feed containing the milk whey protein concentrate or the milk whey protein concentrate degradation product obtained in Example 5 is fed to flounder to prevent infection against HRV. I checked. Two types of flounder feed containing healthy flounder (average weight 80 g) containing the milk whey protein concentrate obtained in Example 5 above or a decomposed product of milk whey protein concentrate,
For comparison, lactoferrin, a lactoferrin degradation product, and a colostrum powder 3% -added diet were given in an amount of 5% of the body weight per day in two divided doses. Each feed-administered group had 10 fish per group. In addition, a group fed a feed to which no additive was added was used as a control. On the 14th day after the first administration of the feed, HRV solution having a titer of 5 × 10 6.8 TCID 50 / ml was applied to 10 flatfish per group.
Each 0.1 ml was intravenously administered. The results are shown in Table 4.

【0045】[0045]

【表4】 [Table 4]

【0046】健常なヒラメにHRV を感染させると、14日
後にはへい死率が4割となるが、本発明のミルクホエー
タンパク質濃縮物、ミルクホエータンパク質濃縮物分解
物添加飼料を与えていたものは、へい死率の低下が認め
られ、特にミルクホエータンパク質濃縮物分解物添加飼
料ではへい死率を1割にくい止めることができ、その効
果は顕著であった。一方、ラクトフェリン、ラクトフェ
リン分解物、初乳粉末添加飼料ではへい死率がコントロ
ールと同様の4割であり、効果は認められなかった。
尚、ウイルスを感染させないヒラメ(ブランク)は試験
期間中全くへい死しなかった。
When healthy flounder was infected with HRV, the mortality rate was 40% after 14 days. However, those fed the feed containing the milk whey protein concentrate and milk whey protein concentrate hydrolyzate of the present invention A decrease in the mortality rate was observed, and the mortality rate could be suppressed to less than 10% with the milk whey protein concentrate hydrolyzate-added feed, and the effect was remarkable. On the other hand, in the lactoferrin, the lactoferrin degradation product, and the colostrum powder-added feed, the mortality rate was 40% as in the control, and no effect was observed.
Flounder (blank) not infected with the virus did not die at all during the test period.

【0047】〔試験例5〕 ギンザケ(Oncorhynchus ki
sutch)を用いたErythrocytic inclusion body syndrome
(EIBS) に対する感染予防効果 実施例6で得られたミルクホエータンパク質濃縮物、又
はミルクホエータンパク質濃縮物分解物を含むギンザケ
用飼料をギンザケに与え、EIBSウイルスに対する感染予
防効果を調べた。健常なギンザケ(平均体重180g) に上
記実施例6で得られたミルクホエータンパク質濃縮物、
又はミルクホエータンパク質濃縮物分解物を含む2種の
ギンザケ用飼料、比較としてラクトフェリン、ラクトフ
ェリン分解物、初乳粉末3%添加飼料を1 日当たり体重
の10% 量を与えた。各飼料投与群は、一群あたり10尾と
した。また、添加物を添加しない飼料を与える群をコン
トロールとした。飼料投与を初めてから14日目に一群あ
たり10尾のギンザケにEIBSウイルス液(感染ギンザケの
頭腎抽出液を0.45μm フィルターでろ過したもの)500μ
l を腹腔内投与した。結果を表5に示す。
Test Example 5 Coho salmon (Oncorhynchus ki)
sutch) Erythrocytic inclusion body syndrome
(EIBS) infection preventive effect The coho salmon feed containing the milk whey protein concentrate obtained in Example 6 or the milk whey protein concentrate degradation product was fed to coho salmon, and the infection preventive effect against EIBS virus was examined. Healthy whey salmon (average weight 180 g) on milk whey protein concentrate obtained in Example 6 above,
Alternatively, two kinds of diets for coho salmon containing a decomposed product of milk whey protein concentrate, for comparison, lactoferrin, a decomposed product of lactoferrin, and a diet containing 3% of colostrum powder were given in an amount of 10% of the body weight per day. Each feed-administered group had 10 fish per group. In addition, a group fed a feed to which no additive was added was used as a control. On the 14th day after the first administration of feed, 500 μ of EIBS virus solution (10% coho salmon per group filtered with 0.45 μm filter of head kidney extract of infected coho salmon)
was administered intraperitoneally. Table 5 shows the results.

【0048】[0048]

【表5】 [Table 5]

【0049】健常なギンザケにEIBSウイルスを感染させ
ると、10日後にはへい死率が8割となるが、本発明のミ
ルクホエータンパク質濃縮物、ミルクホエータンパク質
濃縮物分解物を与えていたものはへい死率の低下が認め
られ、特にミルクホエータンパク質濃縮物分解物添加飼
料ではへい死率を1割にくい止めることができ、その効
果が顕著であった。一方、ラクトフェリン、ラクトフェ
リン分解物、初乳粉末添加飼料ではへい死率がコントロ
ールと同様の8割であり、効果は認められなかった。
尚、ウイルスを感染させないギンザケ(ブランク)は試
験期間中全くへい死しなかった。
Infection of healthy coho salmon with EIBS virus resulted in 80% mortality after 10 days, but those given the milk whey protein concentrate or milk whey protein concentrate degradation product of the present invention died. A decrease in the rate was observed, and the mortality rate of mortality could be suppressed to less than 10% particularly with the milk whey protein concentrate hydrolyzate-added feed, and the effect was remarkable. On the other hand, in the lactoferrin, the lactoferrin degradation product, and the colostrum powder-added feed, the mortality rate was 80% as in the control, and no effect was observed.
Coho salmon (blank) not infected with the virus did not die at all during the test period.

【0050】〔試験例6〕 シマアジ(Pseudocaranx de
tex)を用いたイリドウイルス感染症に対する感染予防効
果 実施例7で得られたミルクホエータンパク質濃縮物、又
はミルクホエータンパク質濃縮物分解物を含むシマアジ
用飼料をシマアジに与え、イリドウイルスに対する感染
予防効果を調べた。健常なシマアジ(平均体重12.5g)に
上記実施例7で得られたミルクホエータンパク質濃縮
物、又はミルクホエータンパク質濃縮物分解物を含む2
種のシマアジ用飼料、比較としてラクトフェリン、ラク
トフェリン分解物、初乳粉末3%添加飼料を1 日当たり
体重の5%量を与えた。各飼料投与群は、一群あたり10
尾とした。また、添加物を添加しない飼料を与える群を
コントロールとした。飼料投与を初めてから14日目に一
群あたり10尾のシマアジにイリドウイルス液(感染シマ
アジの脾臓抽出液を0.45μm フィルターでろ過したも
の) 200 μl を腹腔内投与した。結果を表6に示す。
Test Example 6 Striped jack (Pseudocaranx de
tex) for preventing infection against iridvirus infections The milk whey protein concentrate obtained in Example 7 or a feed for striped horse mackerel containing the decomposed product of milk whey protein concentrate is given to striped horse mackerel, and the infection preventive effect against ylide virus is obtained. I checked. A healthy striped horse mackerel (average weight: 12.5 g) containing the milk whey protein concentrate obtained in Example 7 or a milk whey protein concentrate degradation product 2
Five kinds of diets for striped horse mackerel, for comparison, lactoferrin, lactoferrin degradation product, and 3% colostrum powder-added diet were given at 5% of body weight per day. 10 for each feed administration group
It has a tail. In addition, a group fed a feed to which no additive was added was used as a control. On the 14th day after the first administration of the feed, 200 μl of the ylidovirus solution (the spleen extract of the infected sardine filtered with a 0.45 μm filter) was intraperitoneally administered to 10 Japanese horse mackerel per group. Table 6 shows the results.

【0051】[0051]

【表6】 [Table 6]

【0052】健常なシマアジにイリドウイルスを感染さ
せると、10日後にはへい死率が8割となるが、本発明の
ミルクホエータンパク質濃縮物、ミルクホエータンパク
質濃縮物分解物添加飼料を与えていたものはへい死率の
低下が認められ、特にミルクホエータンパク質濃縮物分
解物添加飼料ではへい死率を1割にくい止めることがで
き、その効果が顕著であった。一方、ラクトフェリン、
ラクトフェリン分解物、初乳粉末添加飼料ではへい死率
がコントロールと同様の8割であり、効果は認められな
かった。尚、ウイルスを感染させないシマアジ(ブラン
ク)は試験期間中全くへい死しなかった。
Infection of healthy striped horse mackerel with iridovirus resulted in 80% mortality after 10 days. However, milk whey protein concentrate of the present invention and milk whey protein concentrate degradation product-added feed were given. A reduction in the mortality rate was observed, and particularly in the milk whey protein concentrate hydrolyzate-added feed, the mortality rate could be suppressed to less than 10%, and the effect was remarkable. On the other hand, lactoferrin,
In the lactoferrin degradation product and the colostrum powder-added feed, the mortality rate was 80% as in the control, and no effect was observed. The horse mackerel (blank) not infected with the virus did not die at all during the test period.

【0053】〔試験例7〕 マダイ(Pagrus major)を用
いたイリドウイルス感染症に対する感染予防効果 実施例8で得られたミルクホエータンパク質濃縮物、又
はミルクホエータンパク質濃縮物分解物を含むマダイ用
飼料をマダイに与え、イリドウイルスに対する感染予防
効果を調べた。健常なマダイ(平均体重15.3g)に上記実
施例8で得られたミルクホエータンパク質濃縮物、又は
ミルクホエータンパク質濃縮物分解物を含む2種のマダ
イ用飼料、比較としてラクトフェリン、ラクトフェリン
分解物、初乳粉末3%添加飼料を1 日当たり体重の5%
量を与えた。各飼料投与群は、一群あたり10尾とした。
また、添加物を添加しない飼料を与える群をコントロー
ルとした。飼料投与を初めてから14日目に一群あたり10
尾のマダイにイリドウイルス液(感染マダイ脾臓抽出液
を0.45μm フィルターでろ過したもの) 200 μl を腹腔
内投与した。結果を表7に示す。
[Test Example 7] Infection prevention effect against iridovirus infection using red sea bream (Pagrus major) The milk whey protein concentrate obtained in Example 8 or a feed for red sea bream containing the decomposed product of milk whey protein concentrate. Was given to the red sea bream and its preventive effect against the iridvirus was examined. Two types of red sea bream feed containing healthy whale (average weight 15.3 g) containing the milk whey protein concentrate obtained in Example 8 or the milk whey protein concentrate degradation product, as a comparison, lactoferrin, lactoferrin degradation product, 5% of body weight per day with 3% milk powder added feed
Given the amount. Each feed-administered group had 10 fish per group.
In addition, a group fed a feed to which no additive was added was used as a control. 10 days per group 14 days after the first feeding
The tail red sea bream was intraperitoneally administered with 200 μl of an iridovirus solution (infected red sea bream spleen extract filtered through a 0.45 μm filter). Table 7 shows the results.

【0054】[0054]

【表7】 [Table 7]

【0055】健常なマダイにイリドウイルスを感染させ
ると、10日後にはへい死率が8割となるが、本発明のミ
ルクホエータンパク質濃縮物、ミルクホエータンパク質
濃縮物分解物添加飼料を与えていたものはへい死率の低
下が認められ、特にミルクホエータンパク質濃縮物分解
物ではへい死率を1割にくい止めることができ、その効
果が顕著であった。一方、ラクトフェリン、ラクトフェ
リン分解物、初乳粉末添加飼料ではへい死率がコントロ
ールと同様の8割であり、効果は認められなかった。
尚、ウイルスを感染させないマダイ(ブランク)は試験
期間中全くへい死しなかった。
Infection of healthy red sea bream with iridovirus results in 80% mortality after 10 days. However, the milk whey protein concentrate and the milk whey protein concentrate hydrolyzate-added feed of the present invention were fed. A reduction in the mortality rate was observed, and in particular, the degradation rate of the milk whey protein concentrate could be suppressed to less than 10%, and the effect was remarkable. On the other hand, in the lactoferrin, the lactoferrin degradation product, and the colostrum powder-added feed, the mortality rate was 80% as in the control, and no effect was observed.
The red sea bream not infected with the virus (blank) did not die at all during the test period.

【0056】〔試験例8〕 ウシエビ(Penaues monodo
n) を用いたVibrio vulnificus に対する感染予防効果 健常なウシエビ(平均体重20g)に1 日2 回、上記実施例
2で得られたミルクホエータンパク質濃縮物、又はミル
クホエータンパク質濃縮物分解物を含む2種の養殖エビ
用飼料、比較としてラクトフェリン、ラクトフェリン分
解物、初乳粉末3%添加飼料を1 日当たり体重の5% 量
与えた。各飼料投与群は、一群あたり10尾とした。ま
た、添加物を添加しない飼料を与える群をコントロール
とした。飼料投与を初めてから14日目に一群あたり10尾
のウシエビを、Vibrio vulnificus5 ×107 CFU/ml海水
に12時間浸し、その後のへい死率を調べた。結果を表8
に示す。
[Test Example 8] Bullfish (Penaues monodo)
n) was used to prevent infection of Vibrio vulnificus against healthy bovine shrimp (average body weight: 20 g) twice a day containing the milk whey protein concentrate or the milk whey protein concentrate degradation product obtained in Example 2 above. 5% of the body weight per day was given to the cultivated shrimp feed, for comparison, lactoferrin, lactoferrin degradation product, and colostrum powder 3% feed. Each feed-administered group had 10 fish per group. In addition, a group fed a feed to which no additive was added was used as a control. On the 14th day after the first administration of the diet, 10 Shrimp per group were soaked in Vibrio vulnificus 5 × 10 7 CFU / ml seawater for 12 hours, and the mortality rate after that was examined. Table 8 shows the results.
Shown in

【0057】[0057]

【表8】 [Table 8]

【0058】健常なウシエビに Vibrio vulnificusを感
染させると、7日後にはへい死率が6割となるが、本発
明のミルクホエータンパク質濃縮物、ミルクホエータン
パク質濃縮物分解物添加飼料を与えていたものはへい死
率の低下が認められ、特にミルクホエータンパク質濃縮
物分解物添加飼料ではへい死率を2割にくい止めること
ができ、その効果が顕著であった。一方、ラクトフェリ
ン、ラクトフェリン分解物、初乳粉末添加飼料ではへい
死率がコントロールと同様の6割であり、効果は認めら
れなかった。尚、ウイルスを感染させないウシエビ(ブ
ランク)は試験期間中全くへい死しなかった。
Infection of healthy bull shrimp with Vibrio vulnificus resulted in 60% mortality after 7 days. However, milk whey protein concentrate of the present invention and milk whey protein concentrate degradation product-added feed were given. A reduction in the mortality rate was observed, and particularly in the milk-whey protein concentrate hydrolyzate-added feed, the mortality rate could be suppressed to 20% or less, and the effect was remarkable. On the other hand, in the lactoferrin, the lactoferrin degradation product, and the colostrum powder-added feed, the mortality rate was 60%, which was the same as the control, and no effect was observed. The shrimp (blank) not infected with the virus did not die at all during the test period.

【0059】〔試験例9〕 ニジマス(Oncorhynchus my
kiss) を用いたVibrio anguillarumに対する感染予防効
果 健常なニジマス(平均体重4g) に上記実施例4で得られ
たミルクホエータンパク質濃縮物、又はミルクホエータ
ンパク質濃縮物分解物を含む2種のニジマス用飼料、比
較としてラクトフェリン、ラクトフェリン分解物、初乳
粉末3%添加飼料を1 日当たり体重の20% 量与えた。各
飼料投与群は、一群あたり10尾とした。また、添加物を
添加しない飼料を与える群をコントロールとした。飼料
投与を初めてから14日目に一群あたり10尾のニジマスに
2.8 ×107CFUの力価のVibrio anguillarum液を50μl ず
つ静脈投与した。結果を表9に示す。
Test Example 9 Rainbow Trout (Oncorhynchus my
infection prevention effect against Vibrio anguillarum using kiss) Two kinds of rainbow trout feeds containing the milk whey protein concentrate obtained in the above Example 4 or the milk whey protein concentrate degradation product in healthy rainbow trout (average weight 4 g) For comparison, lactoferrin, lactoferrin degradation product, and colostrum powder 3% -added feed were given in an amount of 20% of the body weight per day. Each feed-administered group had 10 fish per group. In addition, a group fed a feed to which no additive was added was used as a control. On the 14th day after the first feed administration, 10 rainbow trouts per group
Vibrio anguillarum solution having a titer of 2.8 × 10 7 CFU was intravenously administered in an amount of 50 µl each. The results are shown in Table 9.

【0060】[0060]

【表9】 [Table 9]

【0061】健常なニジマスにVibrio anguillarumを感
染させると、10日後にはへい死率が8割となるが、本発
明のミルクホエータンパク質濃縮物、ミルクホエータン
パク質濃縮物分解物添加飼料を与えていたものはへい死
率の低下が認められ、特にミルクホエータンパク質濃縮
物分解物添加飼料ではへい死率を1割にくい止めること
ができ、その効果が顕著であった。一方、ラクトフェリ
ン、ラクトフェリン分解物、初乳粉末添加飼料ではへい
死率がコントロールと同様の8割であり、効果は認めら
れなかった。尚、ウイルスを感染させないニジマス(ブ
ランク)は試験期間中全くへい死しなかった。
Infection of healthy rainbow trout with Vibrio anguillarum resulted in 80% mortality after 10 days. However, milk whey protein concentrate of the present invention and milk whey protein concentrate degradation product-added feed were given. A reduction in the mortality rate was observed, and particularly in the milk whey protein concentrate hydrolyzate-added feed, the mortality rate could be suppressed to less than 10%, and the effect was remarkable. On the other hand, in the lactoferrin, the lactoferrin degradation product, and the colostrum powder-added feed, the mortality rate was 80% as in the control, and no effect was observed. Rainbow trout (blank) not infected with the virus did not die at all during the test period.

【0062】[0062]

【発明の効果】本発明によれば、魚類及び甲殻類の感染
症に有効な感染症予防治療剤及び飼料が提供される。
INDUSTRIAL APPLICABILITY According to the present invention, a preventive / therapeutic agent for infectious diseases and a feed effective for infectious diseases of fish and crustaceans are provided.

【0063】本発明の感染症予防治療剤及び飼料は、ミ
ルクホエー、又はミルクホエー分解物を有効成分とする
点において安全性の点においても問題はない。
The infectious disease preventive / therapeutic agent and feed of the present invention have no problem in terms of safety in that they contain milk whey or a decomposed product of milk whey as an active ingredient.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A23K 1/18 A23K 1/18 B A61K 38/00 AFF A61K 37/02 AFF (72)発明者 中島 浩 茨城県つくば市和台16−2 マルハ株式会 社中央研究所内 (72)発明者 佐藤 信行 茨城県つくば市和台16−2 マルハ株式会 社中央研究所内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Office reference number FI technical display location A23K 1/18 A23K 1/18 B A61K 38/00 AFF A61K 37/02 AFF (72) Inventor Nakajima Hiroshi Maruha Co., Ltd. 16-2, Wadai, Tsukuba, Ibaraki Prefecture (72) Inventor Nobuyuki Sato 16-2 Wadai, Tsuruba, Ibaraki, Maruha Co., Ltd. Central Research Institute

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 ミルクホエー、又はミルクホエー分解物
を有効成分とする魚類、甲殻類の感染症予防治療剤。
1. A preventive / therapeutic agent for infectious diseases of fish and crustaceans, which comprises milk whey or a decomposed product of milk whey as an active ingredient.
【請求項2】 ミルクホエー、又はミルクホエー分解物
を含有する魚類、甲殻類用飼料。
2. A feed for fish and crustaceans containing milk whey or a decomposed product of milk whey.
JP8156424A 1996-05-29 1996-05-29 Preventing and therapeutic agent for infectious disease and feed Pending JPH09315983A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8156424A JPH09315983A (en) 1996-05-29 1996-05-29 Preventing and therapeutic agent for infectious disease and feed

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8156424A JPH09315983A (en) 1996-05-29 1996-05-29 Preventing and therapeutic agent for infectious disease and feed

Publications (1)

Publication Number Publication Date
JPH09315983A true JPH09315983A (en) 1997-12-09

Family

ID=15627453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8156424A Pending JPH09315983A (en) 1996-05-29 1996-05-29 Preventing and therapeutic agent for infectious disease and feed

Country Status (1)

Country Link
JP (1) JPH09315983A (en)

Similar Documents

Publication Publication Date Title
JP4664678B2 (en) Antibacterial compositions and methods for use
JP4727989B2 (en) Feed composition and method for feeding animals
US20030068670A1 (en) Bioactive peptides, uses thereof and process for the production of same
US4320150A (en) Lactose-rich animal feed formulations and method of feeding animals
EP0826310A1 (en) FEED COMPOSITION CONTAINING POLY-$g(g)-GLUTAMIC ACID
JPH06181656A (en) Preventive/medicine for viral disease in fish and crustacean and feed containing the same
JP2526733B2 (en) Agent for preventing and treating bacterial diseases of fish and crustaceans
JP4056099B2 (en) Preventive and therapeutic agents for parasitic diseases in aquatic animals
JP2016149956A (en) Growth performance improvement agent for feeding period young-age pigs and assorted feed for feeding period young-age pigs
JPH09315983A (en) Preventing and therapeutic agent for infectious disease and feed
JP2010077056A (en) Infectious disease prophylactic
JPH0739351B2 (en) Method to increase water intake by boosting water intake of livestock or pets
JP2001190231A (en) Antimicrobial composition for fish breeding and method for using the same
WO2014025019A1 (en) Animal feed and stress reducer for industrial animals
Tauson Effects of lactic acid bacteria as feed additive on reproductive performance and early kit growth rate in mink and blue foxes
JP3744020B2 (en) Immune enhancer and crustacean, fish and livestock feed containing the same
JP3643407B2 (en) Aquatic animal feed
CA2838550A1 (en) Nutritional supplement, method for increasing the bacterial mass in the rumen of a ruminant and nutritional preparation and corresponding uses
JPH1045600A (en) Preventive and therapeutic agent for infectious disease of crustaceans and fishes and feed containing the same
RU2786666C1 (en) Protein feed supplement for industrial aquaculture
Hu et al. Effects of yeast hydrolysate versus plasma powder on growth, immunity, and intestinal morphology of weanling piglets
JPH0211519A (en) Weight-increasing and immunoenhancing substance, its production and feed containing the same substance
Gatnau et al. Spray-dried porcine plasma (SDPP) as an alternative ingredient in diets of weanling pigs.
CA1179547A (en) Animal lactose-rich feed formulations and method of feed of animals
Nouri et al. Acid hydrolysis of gelatin extracted from cow skin: properties and potential for use as a source of small peptides and free amino acids for broiler chickens

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061017

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071002